Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32

Phase 4TerminatedNCT00047606

Alcon Research84 enrolled

Overview

The purpose of this study is to evaluate safety and efficacy of two different IOP lowering medications after six weeks of treatment in Caucasian and Japanese subjects.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Open-angle Glaucoma Ocular Hypertension

Interventions

IOP Lowering MedicationsDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Adults of Caucasian and Japanese Ethnicity

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.